Registration
FABIANI & COMPANY for OCERA THERAPEUTICS INC.
Firm
Client
Income
—
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Defense DEF
Funding for biopharmaceutical product development with DOD to address nuclear warfare threats and treat long term health impact of chronic substance abuse.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHEN R CONAFAY New | — |
| MELISSA DUPREE New | — |
| JAMES P FABIANI New | — |
| ERIN FRY New | — |
| MARTIN GREEN New | — |
| DANIELLE ORGAN PETERS New | — |
| WENDY SHELTON New | — |
Health Issues HCR
Funding for biopharmaceutical product development with DOD to address nuclear warfare threats and treat long term health impact of chronic substance abuse.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHEN R CONAFAY New | — |
| MELISSA DUPREE New | — |
| JAMES P FABIANI New | — |
| ERIN FRY New | — |
| MARTIN GREEN New | — |
| DANIELLE ORGAN PETERS New | — |
| WENDY SHELTON New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.